nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Carmustine—malignant glioma	0.468	1	CbGbCtD
Tizanidine—Cerebral infarction—Carmustine—malignant glioma	0.0149	0.0284	CcSEcCtD
Tizanidine—Retinal haemorrhage—Carmustine—malignant glioma	0.0149	0.0284	CcSEcCtD
Tizanidine—Hemiplegia—Carmustine—malignant glioma	0.0136	0.0259	CcSEcCtD
Tizanidine—Hemiplegia—Temozolomide—malignant glioma	0.0131	0.025	CcSEcCtD
Tizanidine—Traumatic liver injury—Temozolomide—malignant glioma	0.0126	0.024	CcSEcCtD
Tizanidine—Myasthenia—Carmustine—malignant glioma	0.0077	0.0147	CcSEcCtD
Tizanidine—Stupor—Carmustine—malignant glioma	0.00648	0.0124	CcSEcCtD
Tizanidine—Scotoma—Carmustine—malignant glioma	0.00637	0.0122	CcSEcCtD
Tizanidine—Menorrhagia—Temozolomide—malignant glioma	0.00632	0.0121	CcSEcCtD
Tizanidine—Hepatotoxicity—Carmustine—malignant glioma	0.00627	0.012	CcSEcCtD
Tizanidine—Herpes zoster—Temozolomide—malignant glioma	0.00621	0.0119	CcSEcCtD
Tizanidine—Scotoma—Temozolomide—malignant glioma	0.00616	0.0118	CcSEcCtD
Tizanidine—Abscess—Carmustine—malignant glioma	0.00612	0.0117	CcSEcCtD
Tizanidine—Hepatotoxicity—Temozolomide—malignant glioma	0.00606	0.0116	CcSEcCtD
Tizanidine—Otitis media—Temozolomide—malignant glioma	0.00601	0.0115	CcSEcCtD
Tizanidine—Petechiae—Temozolomide—malignant glioma	0.00569	0.0109	CcSEcCtD
Tizanidine—Speech disorder—Carmustine—malignant glioma	0.00563	0.0107	CcSEcCtD
Tizanidine—Liver injury—Temozolomide—malignant glioma	0.00556	0.0106	CcSEcCtD
Tizanidine—Speech disorder—Temozolomide—malignant glioma	0.00544	0.0104	CcSEcCtD
Tizanidine—Thinking abnormal—Carmustine—malignant glioma	0.00529	0.0101	CcSEcCtD
Tizanidine—Leukocytosis—Carmustine—malignant glioma	0.00515	0.00984	CcSEcCtD
Tizanidine—Herpes simplex—Temozolomide—malignant glioma	0.00508	0.00969	CcSEcCtD
Tizanidine—Neck pain—Carmustine—malignant glioma	0.0049	0.00936	CcSEcCtD
Tizanidine—Pulmonary embolism—Carmustine—malignant glioma	0.00484	0.00924	CcSEcCtD
Tizanidine—Pulmonary embolism—Temozolomide—malignant glioma	0.00468	0.00893	CcSEcCtD
Tizanidine—Vaginal inflammation—Temozolomide—malignant glioma	0.00468	0.00893	CcSEcCtD
Tizanidine—Depressed level of consciousness—Carmustine—malignant glioma	0.00467	0.00893	CcSEcCtD
Tizanidine—Candida infection—Carmustine—malignant glioma	0.00462	0.00883	CcSEcCtD
Tizanidine—Neuropathy—Carmustine—malignant glioma	0.00454	0.00868	CcSEcCtD
Tizanidine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00452	0.00863	CcSEcCtD
Tizanidine—Candida infection—Temozolomide—malignant glioma	0.00447	0.00853	CcSEcCtD
Tizanidine—Vaginal infection—Temozolomide—malignant glioma	0.00442	0.00843	CcSEcCtD
Tizanidine—Neuropathy—Temozolomide—malignant glioma	0.00439	0.00839	CcSEcCtD
Tizanidine—Mental disability—Carmustine—malignant glioma	0.0042	0.00802	CcSEcCtD
Tizanidine—Sepsis—Carmustine—malignant glioma	0.0042	0.00802	CcSEcCtD
Tizanidine—Phlebitis—Carmustine—malignant glioma	0.00408	0.00779	CcSEcCtD
Tizanidine—Mental disability—Temozolomide—malignant glioma	0.00406	0.00775	CcSEcCtD
Tizanidine—Ear pain—Temozolomide—malignant glioma	0.00398	0.0076	CcSEcCtD
Tizanidine—Eye pain—Carmustine—malignant glioma	0.00389	0.00743	CcSEcCtD
Tizanidine—Gastroenteritis—Temozolomide—malignant glioma	0.00383	0.00732	CcSEcCtD
Tizanidine—Vascular purpura—Temozolomide—malignant glioma	0.0038	0.00725	CcSEcCtD
Tizanidine—Deafness—Temozolomide—malignant glioma	0.0038	0.00725	CcSEcCtD
Tizanidine—Hepatic failure—Temozolomide—malignant glioma	0.00378	0.00722	CcSEcCtD
Tizanidine—Eye pain—Temozolomide—malignant glioma	0.00376	0.00718	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0036	0.00687	CcSEcCtD
Tizanidine—Hyponatraemia—Carmustine—malignant glioma	0.00353	0.00674	CcSEcCtD
Tizanidine—Purpura—Temozolomide—malignant glioma	0.00352	0.00673	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00351	0.00671	CcSEcCtD
Tizanidine—Affect lability—Temozolomide—malignant glioma	0.00334	0.00638	CcSEcCtD
Tizanidine—Liver function test abnormal—Carmustine—malignant glioma	0.00324	0.0062	CcSEcCtD
Tizanidine—Mood swings—Temozolomide—malignant glioma	0.00322	0.00614	CcSEcCtD
Tizanidine—Hypokalaemia—Carmustine—malignant glioma	0.0032	0.00611	CcSEcCtD
Tizanidine—Dry skin—Temozolomide—malignant glioma	0.00311	0.00594	CcSEcCtD
Tizanidine—Muscular weakness—Carmustine—malignant glioma	0.0031	0.00592	CcSEcCtD
Tizanidine—Hypokalaemia—Temozolomide—malignant glioma	0.00309	0.0059	CcSEcCtD
Tizanidine—Dysphagia—Carmustine—malignant glioma	0.00304	0.0058	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00299	0.00572	CcSEcCtD
Tizanidine—Muscular weakness—Temozolomide—malignant glioma	0.00299	0.00572	CcSEcCtD
Tizanidine—Dysphagia—Temozolomide—malignant glioma	0.00293	0.0056	CcSEcCtD
Tizanidine—Bronchitis—Temozolomide—malignant glioma	0.00282	0.00539	CcSEcCtD
Tizanidine—Hyperglycaemia—Carmustine—malignant glioma	0.00274	0.00523	CcSEcCtD
Tizanidine—Pneumonia—Carmustine—malignant glioma	0.00272	0.0052	CcSEcCtD
Tizanidine—Pollakiuria—Temozolomide—malignant glioma	0.00271	0.00518	CcSEcCtD
Tizanidine—Depression—Carmustine—malignant glioma	0.0027	0.00516	CcSEcCtD
Tizanidine—Renal failure—Carmustine—malignant glioma	0.00266	0.00508	CcSEcCtD
Tizanidine—Weight decreased—Temozolomide—malignant glioma	0.00265	0.00507	CcSEcCtD
Tizanidine—Neuropathy peripheral—Carmustine—malignant glioma	0.00265	0.00507	CcSEcCtD
Tizanidine—Hyperglycaemia—Temozolomide—malignant glioma	0.00265	0.00506	CcSEcCtD
Tizanidine—Pneumonia—Temozolomide—malignant glioma	0.00263	0.00503	CcSEcCtD
Tizanidine—Depression—Temozolomide—malignant glioma	0.00261	0.00498	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00259	0.00495	CcSEcCtD
Tizanidine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00256	0.0049	CcSEcCtD
Tizanidine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00247	0.00473	CcSEcCtD
Tizanidine—Sinusitis—Temozolomide—malignant glioma	0.00245	0.00469	CcSEcCtD
Tizanidine—Haemoglobin—Carmustine—malignant glioma	0.00244	0.00467	CcSEcCtD
Tizanidine—Haemorrhage—Carmustine—malignant glioma	0.00243	0.00464	CcSEcCtD
Tizanidine—Hallucination—Carmustine—malignant glioma	0.00242	0.00462	CcSEcCtD
Tizanidine—Connective tissue disorder—Carmustine—malignant glioma	0.00239	0.00456	CcSEcCtD
Tizanidine—Haemoglobin—Temozolomide—malignant glioma	0.00236	0.00451	CcSEcCtD
Tizanidine—Haemorrhage—Temozolomide—malignant glioma	0.00235	0.00449	CcSEcCtD
Tizanidine—Hepatitis—Temozolomide—malignant glioma	0.00235	0.00449	CcSEcCtD
Tizanidine—Hallucination—Temozolomide—malignant glioma	0.00234	0.00446	CcSEcCtD
Tizanidine—Pharyngitis—Temozolomide—malignant glioma	0.00233	0.00445	CcSEcCtD
Tizanidine—Urinary tract disorder—Temozolomide—malignant glioma	0.00232	0.00443	CcSEcCtD
Tizanidine—Connective tissue disorder—Temozolomide—malignant glioma	0.00231	0.00441	CcSEcCtD
Tizanidine—Urethral disorder—Temozolomide—malignant glioma	0.0023	0.0044	CcSEcCtD
Tizanidine—Erythema multiforme—Temozolomide—malignant glioma	0.00222	0.00424	CcSEcCtD
Tizanidine—Tinnitus—Temozolomide—malignant glioma	0.00219	0.00418	CcSEcCtD
Tizanidine—Cardiac disorder—Temozolomide—malignant glioma	0.00218	0.00416	CcSEcCtD
Tizanidine—Arrhythmia—Carmustine—malignant glioma	0.00217	0.00415	CcSEcCtD
Tizanidine—Alopecia—Carmustine—malignant glioma	0.00215	0.0041	CcSEcCtD
Tizanidine—Angiopathy—Temozolomide—malignant glioma	0.00213	0.00407	CcSEcCtD
Tizanidine—Mental disorder—Carmustine—malignant glioma	0.00213	0.00407	CcSEcCtD
Tizanidine—Immune system disorder—Temozolomide—malignant glioma	0.00212	0.00405	CcSEcCtD
Tizanidine—Mediastinal disorder—Temozolomide—malignant glioma	0.00212	0.00404	CcSEcCtD
Tizanidine—Alopecia—Temozolomide—malignant glioma	0.00208	0.00396	CcSEcCtD
Tizanidine—Mental disorder—Temozolomide—malignant glioma	0.00206	0.00393	CcSEcCtD
Tizanidine—Back pain—Carmustine—malignant glioma	0.00205	0.00391	CcSEcCtD
Tizanidine—Vision blurred—Carmustine—malignant glioma	0.00199	0.00381	CcSEcCtD
Tizanidine—Tremor—Carmustine—malignant glioma	0.00198	0.00379	CcSEcCtD
Tizanidine—Back pain—Temozolomide—malignant glioma	0.00198	0.00378	CcSEcCtD
Tizanidine—Anaemia—Carmustine—malignant glioma	0.00196	0.00374	CcSEcCtD
Tizanidine—Agitation—Carmustine—malignant glioma	0.00194	0.00371	CcSEcCtD
Tizanidine—Vision blurred—Temozolomide—malignant glioma	0.00193	0.00368	CcSEcCtD
Tizanidine—Tremor—Temozolomide—malignant glioma	0.00192	0.00366	CcSEcCtD
Tizanidine—Ill-defined disorder—Temozolomide—malignant glioma	0.0019	0.00362	CcSEcCtD
Tizanidine—Leukopenia—Carmustine—malignant glioma	0.00189	0.00362	CcSEcCtD
Tizanidine—Anaemia—Temozolomide—malignant glioma	0.00189	0.00361	CcSEcCtD
Tizanidine—Agitation—Temozolomide—malignant glioma	0.00188	0.00359	CcSEcCtD
Tizanidine—Malaise—Temozolomide—malignant glioma	0.00184	0.00352	CcSEcCtD
Tizanidine—Vertigo—Temozolomide—malignant glioma	0.00184	0.00351	CcSEcCtD
Tizanidine—Convulsion—Carmustine—malignant glioma	0.00183	0.0035	CcSEcCtD
Tizanidine—Leukopenia—Temozolomide—malignant glioma	0.00183	0.0035	CcSEcCtD
Tizanidine—Hypertension—Carmustine—malignant glioma	0.00183	0.00349	CcSEcCtD
Tizanidine—Anxiety—Carmustine—malignant glioma	0.0018	0.00343	CcSEcCtD
Tizanidine—Convulsion—Temozolomide—malignant glioma	0.00177	0.00338	CcSEcCtD
Tizanidine—Hypertension—Temozolomide—malignant glioma	0.00177	0.00337	CcSEcCtD
Tizanidine—Confusional state—Carmustine—malignant glioma	0.00174	0.00333	CcSEcCtD
Tizanidine—Arthralgia—Temozolomide—malignant glioma	0.00174	0.00332	CcSEcCtD
Tizanidine—Anxiety—Temozolomide—malignant glioma	0.00173	0.00331	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00173	0.0033	CcSEcCtD
Tizanidine—Oedema—Carmustine—malignant glioma	0.00173	0.0033	CcSEcCtD
Tizanidine—Discomfort—Temozolomide—malignant glioma	0.00172	0.00328	CcSEcCtD
Tizanidine—Infection—Carmustine—malignant glioma	0.00172	0.00328	CcSEcCtD
Tizanidine—Dry mouth—Temozolomide—malignant glioma	0.0017	0.00325	CcSEcCtD
Tizanidine—Thrombocytopenia—Carmustine—malignant glioma	0.00169	0.00323	CcSEcCtD
Tizanidine—Tachycardia—Carmustine—malignant glioma	0.00169	0.00322	CcSEcCtD
Tizanidine—Confusional state—Temozolomide—malignant glioma	0.00168	0.00321	CcSEcCtD
Tizanidine—Oedema—Temozolomide—malignant glioma	0.00167	0.00319	CcSEcCtD
Tizanidine—Anaphylactic shock—Temozolomide—malignant glioma	0.00167	0.00319	CcSEcCtD
Tizanidine—Infection—Temozolomide—malignant glioma	0.00166	0.00317	CcSEcCtD
Tizanidine—Nervous system disorder—Temozolomide—malignant glioma	0.00164	0.00313	CcSEcCtD
Tizanidine—Thrombocytopenia—Temozolomide—malignant glioma	0.00163	0.00312	CcSEcCtD
Tizanidine—Skin disorder—Temozolomide—malignant glioma	0.00162	0.0031	CcSEcCtD
Tizanidine—Hypotension—Carmustine—malignant glioma	0.00161	0.00308	CcSEcCtD
Tizanidine—Hyperhidrosis—Temozolomide—malignant glioma	0.00161	0.00308	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00157	0.003	CcSEcCtD
Tizanidine—Paraesthesia—Carmustine—malignant glioma	0.00155	0.00296	CcSEcCtD
Tizanidine—Dyspnoea—Carmustine—malignant glioma	0.00154	0.00294	CcSEcCtD
Tizanidine—Somnolence—Carmustine—malignant glioma	0.00154	0.00293	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00152	0.0029	CcSEcCtD
Tizanidine—Paraesthesia—Temozolomide—malignant glioma	0.0015	0.00286	CcSEcCtD
Tizanidine—Dyspnoea—Temozolomide—malignant glioma	0.00149	0.00284	CcSEcCtD
Tizanidine—Somnolence—Temozolomide—malignant glioma	0.00148	0.00283	CcSEcCtD
Tizanidine—Constipation—Carmustine—malignant glioma	0.00148	0.00282	CcSEcCtD
Tizanidine—Dyspepsia—Temozolomide—malignant glioma	0.00147	0.00281	CcSEcCtD
Tizanidine—Fatigue—Temozolomide—malignant glioma	0.00144	0.00275	CcSEcCtD
Tizanidine—Constipation—Temozolomide—malignant glioma	0.00143	0.00273	CcSEcCtD
Tizanidine—Feeling abnormal—Carmustine—malignant glioma	0.00142	0.00272	CcSEcCtD
Tizanidine—Gastrointestinal pain—Carmustine—malignant glioma	0.00141	0.0027	CcSEcCtD
Tizanidine—Feeling abnormal—Temozolomide—malignant glioma	0.00138	0.00263	CcSEcCtD
Tizanidine—Body temperature increased—Carmustine—malignant glioma	0.00137	0.00261	CcSEcCtD
Tizanidine—Abdominal pain—Carmustine—malignant glioma	0.00137	0.00261	CcSEcCtD
Tizanidine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00136	0.00261	CcSEcCtD
Tizanidine—Urticaria—Temozolomide—malignant glioma	0.00133	0.00253	CcSEcCtD
Tizanidine—Abdominal pain—Temozolomide—malignant glioma	0.00132	0.00252	CcSEcCtD
Tizanidine—Body temperature increased—Temozolomide—malignant glioma	0.00132	0.00252	CcSEcCtD
Tizanidine—Hypersensitivity—Carmustine—malignant glioma	0.00127	0.00243	CcSEcCtD
Tizanidine—Asthenia—Carmustine—malignant glioma	0.00124	0.00237	CcSEcCtD
Tizanidine—Hypersensitivity—Temozolomide—malignant glioma	0.00123	0.00235	CcSEcCtD
Tizanidine—Asthenia—Temozolomide—malignant glioma	0.0012	0.00229	CcSEcCtD
Tizanidine—Diarrhoea—Carmustine—malignant glioma	0.00118	0.00226	CcSEcCtD
Tizanidine—Pruritus—Temozolomide—malignant glioma	0.00118	0.00225	CcSEcCtD
Tizanidine—Dizziness—Carmustine—malignant glioma	0.00114	0.00218	CcSEcCtD
Tizanidine—Diarrhoea—Temozolomide—malignant glioma	0.00114	0.00218	CcSEcCtD
Tizanidine—Dizziness—Temozolomide—malignant glioma	0.0011	0.00211	CcSEcCtD
Tizanidine—Vomiting—Carmustine—malignant glioma	0.0011	0.0021	CcSEcCtD
Tizanidine—Rash—Carmustine—malignant glioma	0.00109	0.00208	CcSEcCtD
Tizanidine—Dermatitis—Carmustine—malignant glioma	0.00109	0.00208	CcSEcCtD
Tizanidine—Vomiting—Temozolomide—malignant glioma	0.00106	0.00203	CcSEcCtD
Tizanidine—Rash—Temozolomide—malignant glioma	0.00105	0.00201	CcSEcCtD
Tizanidine—Dermatitis—Temozolomide—malignant glioma	0.00105	0.00201	CcSEcCtD
Tizanidine—Nausea—Carmustine—malignant glioma	0.00103	0.00196	CcSEcCtD
Tizanidine—Nausea—Temozolomide—malignant glioma	0.000991	0.00189	CcSEcCtD
Tizanidine—ADRA2C—Signaling by GPCR—AKT2—malignant glioma	5.06e-06	0.000591	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NTRK1—malignant glioma	5.03e-06	0.000588	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NTRK2—malignant glioma	5.02e-06	0.000585	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—YWHAE—malignant glioma	5.02e-06	0.000585	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP3—malignant glioma	5.01e-06	0.000585	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CB—malignant glioma	5e-06	0.000583	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FLT1—malignant glioma	4.99e-06	0.000583	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—DUSP6—malignant glioma	4.97e-06	0.00058	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN2B—malignant glioma	4.97e-06	0.00058	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CG—malignant glioma	4.95e-06	0.000577	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JAG1—malignant glioma	4.91e-06	0.000573	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—KRAS—malignant glioma	4.9e-06	0.000572	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH3—malignant glioma	4.89e-06	0.000571	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CD—malignant glioma	4.86e-06	0.000568	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—IDH1—malignant glioma	4.83e-06	0.000564	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTK2—malignant glioma	4.82e-06	0.000563	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PIK3CA—malignant glioma	4.82e-06	0.000563	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FBXW7—malignant glioma	4.81e-06	0.000561	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL8—malignant glioma	4.8e-06	0.00056	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HES1—malignant glioma	4.74e-06	0.000553	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BDKRB2—malignant glioma	4.72e-06	0.00055	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NCOR1—malignant glioma	4.71e-06	0.00055	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—F2—malignant glioma	4.69e-06	0.000548	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—malignant glioma	4.68e-06	0.000546	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP3—malignant glioma	4.68e-06	0.000546	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SPHK1—malignant glioma	4.67e-06	0.000546	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CB—malignant glioma	4.67e-06	0.000545	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TP53—malignant glioma	4.66e-06	0.000544	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTP1—malignant glioma	4.65e-06	0.000543	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—RAF1—malignant glioma	4.65e-06	0.000542	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN2B—malignant glioma	4.64e-06	0.000541	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—IL2—malignant glioma	4.59e-06	0.000536	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2C18—malignant glioma	4.58e-06	0.000535	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CB—malignant glioma	4.54e-06	0.00053	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT2—malignant glioma	4.53e-06	0.000528	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAT—malignant glioma	4.53e-06	0.000528	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PDGFRA—malignant glioma	4.51e-06	0.000527	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTK2—malignant glioma	4.5e-06	0.000526	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PIK3CA—malignant glioma	4.5e-06	0.000525	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CG—malignant glioma	4.49e-06	0.000524	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL8—malignant glioma	4.48e-06	0.000523	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HES1—malignant glioma	4.43e-06	0.000517	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PTPN11—malignant glioma	4.41e-06	0.000515	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NCOR1—malignant glioma	4.4e-06	0.000514	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH2—malignant glioma	4.38e-06	0.000512	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SPP1—malignant glioma	4.38e-06	0.000511	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL8—malignant glioma	4.36e-06	0.000509	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TP53—malignant glioma	4.35e-06	0.000508	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CD—malignant glioma	4.35e-06	0.000508	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—RAF1—malignant glioma	4.34e-06	0.000507	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.32e-06	0.000504	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KNG1—malignant glioma	4.29e-06	0.000501	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CAV1—malignant glioma	4.29e-06	0.000501	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—IL2—malignant glioma	4.29e-06	0.0005	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NCOR1—malignant glioma	4.27e-06	0.000499	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CB—malignant glioma	4.24e-06	0.000495	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PDGFRA—malignant glioma	4.21e-06	0.000492	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL2—malignant glioma	4.17e-06	0.000486	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TERT—malignant glioma	4.15e-06	0.000485	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT2—malignant glioma	4.11e-06	0.00048	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SPP1—malignant glioma	4.09e-06	0.000477	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NTRK1—malignant glioma	4.09e-06	0.000477	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—malignant glioma	4.07e-06	0.000475	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PDGFB—malignant glioma	4.05e-06	0.000473	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGFR1—malignant glioma	4.03e-06	0.000471	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—KRAS—malignant glioma	3.98e-06	0.000465	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—malignant glioma	3.97e-06	0.000463	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	3.95e-06	0.000461	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—malignant glioma	3.94e-06	0.00046	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.93e-06	0.000459	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—malignant glioma	3.91e-06	0.000456	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL2—malignant glioma	3.89e-06	0.000454	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TERT—malignant glioma	3.88e-06	0.000453	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CAV1—malignant glioma	3.84e-06	0.000448	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP3—malignant glioma	3.8e-06	0.000444	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—malignant glioma	3.8e-06	0.000443	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.8e-06	0.000443	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	3.79e-06	0.000442	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PDGFB—malignant glioma	3.78e-06	0.000442	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—malignant glioma	3.77e-06	0.00044	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	3.77e-06	0.00044	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGFR1—malignant glioma	3.76e-06	0.00044	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—malignant glioma	3.71e-06	0.000433	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTT1—malignant glioma	3.7e-06	0.000432	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—malignant glioma	3.68e-06	0.000429	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTK2—malignant glioma	3.66e-06	0.000427	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—malignant glioma	3.66e-06	0.000427	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FN1—malignant glioma	3.65e-06	0.000427	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—F2—malignant glioma	3.65e-06	0.000427	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	3.64e-06	0.000425	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BAD—malignant glioma	3.61e-06	0.000422	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HES1—malignant glioma	3.59e-06	0.00042	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CAV1—malignant glioma	3.59e-06	0.000419	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	3.58e-06	0.000417	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	3.57e-06	0.000417	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—malignant glioma	3.55e-06	0.000414	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—malignant glioma	3.54e-06	0.000413	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	3.53e-06	0.000412	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CD80—malignant glioma	3.5e-06	0.000409	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APC—malignant glioma	3.5e-06	0.000408	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	3.5e-06	0.000408	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAV1—malignant glioma	3.48e-06	0.000407	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	3.48e-06	0.000406	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS1—malignant glioma	3.47e-06	0.000405	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.46e-06	0.000404	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGF—malignant glioma	3.46e-06	0.000404	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	3.44e-06	0.000402	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	3.44e-06	0.000401	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CD—malignant glioma	3.43e-06	0.000401	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	3.42e-06	0.0004	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FN1—malignant glioma	3.41e-06	0.000399	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—F2—malignant glioma	3.41e-06	0.000399	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BAD—malignant glioma	3.37e-06	0.000394	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH1—malignant glioma	3.34e-06	0.00039	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SPP1—malignant glioma	3.32e-06	0.000388	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	3.31e-06	0.000386	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BRAF—malignant glioma	3.29e-06	0.000384	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CD80—malignant glioma	3.27e-06	0.000382	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APC—malignant glioma	3.27e-06	0.000381	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—malignant glioma	3.27e-06	0.000381	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGF—malignant glioma	3.23e-06	0.000377	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—BCHE—malignant glioma	3.23e-06	0.000377	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTPN11—malignant glioma	3.21e-06	0.000375	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT2—malignant glioma	3.2e-06	0.000374	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.19e-06	0.000372	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	3.19e-06	0.000372	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—malignant glioma	3.17e-06	0.00037	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL2—malignant glioma	3.16e-06	0.000369	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TERT—malignant glioma	3.15e-06	0.000368	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	3.07e-06	0.000359	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	3.07e-06	0.000359	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BRAF—malignant glioma	3.07e-06	0.000358	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—malignant glioma	3.06e-06	0.000358	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	3.06e-06	0.000357	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	3.05e-06	0.000356	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.01e-06	0.000352	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	3.01e-06	0.000352	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	3.01e-06	0.000351	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CB—malignant glioma	2.99e-06	0.000349	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT2—malignant glioma	2.99e-06	0.000349	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—malignant glioma	2.99e-06	0.000349	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.99e-06	0.000349	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	2.98e-06	0.000347	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—malignant glioma	2.97e-06	0.000346	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGF2—malignant glioma	2.94e-06	0.000344	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CAV1—malignant glioma	2.91e-06	0.00034	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—malignant glioma	2.88e-06	0.000336	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	2.87e-06	0.000335	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	2.84e-06	0.000332	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	2.81e-06	0.000328	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CD—malignant glioma	2.79e-06	0.000326	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—F2—malignant glioma	2.77e-06	0.000324	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FN1—malignant glioma	2.77e-06	0.000324	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	2.77e-06	0.000323	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MDM2—malignant glioma	2.75e-06	0.000322	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGF2—malignant glioma	2.75e-06	0.000321	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAF1—malignant glioma	2.74e-06	0.00032	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BAD—malignant glioma	2.74e-06	0.00032	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	2.72e-06	0.000317	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	2.71e-06	0.000317	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	2.68e-06	0.000313	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CD80—malignant glioma	2.66e-06	0.00031	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APC—malignant glioma	2.65e-06	0.00031	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	2.65e-06	0.00031	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGF—malignant glioma	2.62e-06	0.000306	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	2.61e-06	0.000304	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.6e-06	0.000304	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTEN—malignant glioma	2.59e-06	0.000302	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	2.58e-06	0.000302	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	2.58e-06	0.000301	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MDM2—malignant glioma	2.57e-06	0.0003	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTP1—malignant glioma	2.57e-06	0.0003	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAF1—malignant glioma	2.56e-06	0.000299	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	2.54e-06	0.000296	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	2.5e-06	0.000292	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAT—malignant glioma	2.5e-06	0.000292	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	2.49e-06	0.000291	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	2.49e-06	0.00029	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—malignant glioma	2.46e-06	0.000288	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL2—malignant glioma	2.46e-06	0.000287	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CB—malignant glioma	2.43e-06	0.000284	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	2.43e-06	0.000283	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	2.42e-06	0.000282	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—malignant glioma	2.41e-06	0.000281	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	2.41e-06	0.000281	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NCOR1—malignant glioma	2.36e-06	0.000275	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	2.33e-06	0.000272	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	2.33e-06	0.000272	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	2.32e-06	0.000271	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	2.32e-06	0.00027	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.31e-06	0.00027	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	2.3e-06	0.000269	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL2—malignant glioma	2.3e-06	0.000268	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	2.28e-06	0.000267	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	2.26e-06	0.000264	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.23e-06	0.000261	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	2.18e-06	0.000254	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	2.16e-06	0.000253	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	2.11e-06	0.000246	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTEN—malignant glioma	2.1e-06	0.000245	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.1e-06	0.000245	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	2.09e-06	0.000244	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.09e-06	0.000244	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.08e-06	0.000243	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	2.07e-06	0.000242	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.06e-06	0.000241	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.03e-06	0.000237	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.95e-06	0.000228	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	1.95e-06	0.000228	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	1.93e-06	0.000226	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—malignant glioma	1.92e-06	0.000225	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAV1—malignant glioma	1.92e-06	0.000225	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.89e-06	0.00022	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	1.88e-06	0.00022	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.87e-06	0.000218	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.87e-06	0.000218	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.84e-06	0.000214	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—malignant glioma	1.82e-06	0.000213	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—malignant glioma	1.8e-06	0.00021	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	1.78e-06	0.000208	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.77e-06	0.000206	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	1.76e-06	0.000205	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.76e-06	0.000205	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.75e-06	0.000205	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.71e-06	0.0002	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—malignant glioma	1.69e-06	0.000197	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	1.66e-06	0.000194	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	1.63e-06	0.000191	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.59e-06	0.000185	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—malignant glioma	1.58e-06	0.000184	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.57e-06	0.000183	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.54e-06	0.00018	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	1.53e-06	0.000178	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—malignant glioma	1.49e-06	0.000174	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.48e-06	0.000173	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—malignant glioma	1.48e-06	0.000172	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.46e-06	0.00017	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.43e-06	0.000167	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.35e-06	0.000157	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.34e-06	0.000157	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1.33e-06	0.000156	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.33e-06	0.000155	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	1.25e-06	0.000146	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.24e-06	0.000145	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—malignant glioma	1.21e-06	0.000141	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.2e-06	0.00014	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTEN—malignant glioma	1.16e-06	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.01e-06	0.000118	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—malignant glioma	8.18e-07	9.55e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—malignant glioma	6.68e-07	7.8e-05	CbGpPWpGaD
